Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Oncology Letters
      • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Biomedical Reports
      • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • Information for Authors
    • Information for Reviewers
    • Information for Librarians
    • Information for Advertisers
    • Conferences
  • Language Editing
Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • For Authors
    • For Reviewers
    • For Librarians
    • For Advertisers
    • Conferences
  • Language Editing
Login Register Submit
  • This site uses cookies
  • You can change your cookie settings at any time by following the instructions in our Cookie Policy. To find out more, you may read our Privacy Policy.

    I agree
Search articles by DOI, keyword, author or affiliation
Search
Advanced Search
presentation
Oncology Letters
Join Editorial Board Propose a Special Issue
Print ISSN: 1792-1074 Online ISSN: 1792-1082
Journal Cover
January-2027 Volume 33 Issue 1

Full Size Image

Sign up for eToc alerts
Recommend to Library

Journals

International Journal of Molecular Medicine

International Journal of Molecular Medicine

International Journal of Molecular Medicine is an international journal devoted to molecular mechanisms of human disease.

International Journal of Oncology

International Journal of Oncology

International Journal of Oncology is an international journal devoted to oncology research and cancer treatment.

Molecular Medicine Reports

Molecular Medicine Reports

Covers molecular medicine topics such as pharmacology, pathology, genetics, neuroscience, infectious diseases, molecular cardiology, and molecular surgery.

Oncology Reports

Oncology Reports

Oncology Reports is an international journal devoted to fundamental and applied research in Oncology.

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine is an international journal devoted to laboratory and clinical medicine.

Oncology Letters

Oncology Letters

Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.

Biomedical Reports

Biomedical Reports

Explores a wide range of biological and medical fields, including pharmacology, genetics, microbiology, neuroscience, and molecular cardiology.

Molecular and Clinical Oncology

Molecular and Clinical Oncology

International journal addressing all aspects of oncology research, from tumorigenesis and oncogenes to chemotherapy and metastasis.

World Academy of Sciences Journal

World Academy of Sciences Journal

Multidisciplinary open-access journal spanning biochemistry, genetics, neuroscience, environmental health, and synthetic biology.

International Journal of Functional Nutrition

International Journal of Functional Nutrition

Open-access journal combining biochemistry, pharmacology, immunology, and genetics to advance health through functional nutrition.

International Journal of Epigenetics

International Journal of Epigenetics

Publishes open-access research on using epigenetics to advance understanding and treatment of human disease.

Medicine International

Medicine International

An International Open Access Journal Devoted to General Medicine.

Journal Cover
January-2027 Volume 33 Issue 1

Full Size Image

Sign up for eToc alerts
Recommend to Library

  • Article
  • Citations
    • Cite This Article
    • Download Citation
    • Create Citation Alert
    • Remove Citation Alert
    • Cited By
  • Similar Articles
    • Related Articles (in Spandidos Publications)
    • Similar Articles (Google Scholar)
    • Similar Articles (PubMed)
  • Download PDF
  • Download XML
  • View XML
Review Special Issue Open Access

Fruit seed extracts: A class of natural anticancer candidate resources (Review)

This article is part of the special Issue: Natural Products: Recent Therapeutic Advances in Oncology Research
  • Authors:
    • Jing Tang
    • Chang Xu
    • Jingkui Tian
    • Ping Wang
    • Xiaoyong Zhang
    • Zhao Wang
  • View Affiliations / Copyright

    Affiliations: College of Pharmaceutical Science, Zhejiang University of Technology, Hangzhou, Zhejiang 310014, P.R. China, Zhejiang Cancer Hospital, Hangzhou Institute of Medicine, Chinese Academy of Sciences, Hangzhou, Zhejiang 310022, P.R. China
    Copyright: © Tang et al. This is an open access article distributed under the terms of Creative Commons Attribution License.
  • Article Number: 8
    |
    Published online on: November 10, 2026
       https://doi.org/10.3892/ol.2026.15943
  • Expand metrics +
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )
Cited By (CrossRef): 0 citations Loading Articles...

This article is mentioned in:


Abstract

The present review aimed to explore the anticancer potential of fruit seeds, focusing on their bioactive components and mechanisms of action to evaluate the application of these natural by‑products in cancer intervention. In the present article, fruits are categorized into four major groups, namely berries, stone fruits (drupes), pepo fruits (melons) and aggregate fruits. The review summarizes the active components in seeds of different families and also explains the anticancer mechanisms of polyphenols, terpenoids and other compounds. Fruit seeds from different plant families contain distinct sets of active compounds. These chemical differences lead to varied anticancer potentials. However, the extraction process needs to be standardized and clinical translation research should be accelerated.

Introduction

Natural products have attracted attention in antitumor research due to their advantages of diverse structures, high safety and rich targets (1). First-line chemotherapy drugs such as paclitaxel, vincristine and camptothecin all originate from secondary metabolites of natural plants. Among the antitumor drugs approved in recent decades, >40% are related to natural products and their derivatives (2,3). Plant secondary metabolites possess advantages such as diverse structures, novel skeletons, good biocompatibility and multi-target effects (4,5). They are an important source for discovering anticancer lead compounds, overcoming drug resistance and developing low-toxicity and highly efficient preparations.

As a by-product of the fruit processing industry, fruit seeds have a huge annual output and have been abandoned or used at low value for a long time, resulting in a waste of resources and environmental pollution (6). Development of the anticancer resources of fruit seeds is in line with the green and low-carbon concepts, as well as a circular economy; it has numerous benefits, including environmental protection, and economic and societal benefits, through the conversion of processing residues into marketable products and the reduction of waste-disposal costs. It is an important direction for the high-value utilization of natural product resources. Compared to the fruit flesh and peel, fruit seeds have a higher content of active components, improved stability and are easier to store. A large number of studies have shown that the content of active substances such as polyphenols, terpenoids, flavonoids, unsaturated fatty acids, polysaccharides and protein peptides in fruit seeds is generally higher than that in the flesh, peel, leaves and stems (7,8). In addition, as the reproductive organ of plants, seeds have a more complex and diverse composition of secondary metabolites, and possess multiple activities such as antioxidant, anti-inflammatory, antitumor and immune regulation activities (6,8). Seeds also have a low water content, hard texture and strong component stability. They are easy to store at room temperature and do not easily deteriorate. The extraction process is simple and the cost is low, making it convenient for industrial-scale development and a good industrialization prospect.

At present, research on the anticancer effects of fruit seeds mainly focuses on scattered reports of a single variety or a single component, lacking systematic organization (9,10). The present review focuses on the representative fruit seeds of four major groups: Berries, stone fruits (drupes), pepo fruits (melons) and aggregate fruits. The review systematically summarizes the family and genus origins and the distribution characteristics of active components of representative fruit seeds in various groups, and clarifies their anticancer molecular mechanisms according to the types of chemical components. To the best of our knowledge, this is one of the first reviews to systematically link plant taxonomic origin with chemical class and anticancer mechanism for fruit seeds, with the aim of providing references for the high-value utilization of fruit seed resources and anticancer strategies based on natural products. The comprehensive overview of anticancer properties of fruit seed bioactive compounds is summarized in Fig. 1.

Graphical summary of fruit
seed-derived anticancer candidates. Created using BioRender
(https://biorender.com/wol3esv).

Figure 1.

Graphical summary of fruit seed-derived anticancer candidates. Created using BioRender (https://biorender.com/wol3esv).

Anticancer activities of seeds from different fruit groups

Berry fruit seeds

Berries mainly include plants from families such as Vitaceae, Myrtaceae and Rosaceae. Their fruits are juicy and soft, with small and numerous seeds. The seeds contain mainly active components such as polyphenols, flavonoids, proanthocyanidins, anthocyanins, unsaturated fatty acids and polysaccharides, and have particularly prominent antioxidant and anti-inflammatory activities (11).

Grape seeds of Vitis vinifera L. are the most systematically and deeply studied resource among the berry types. The seeds of grapes are rich in proanthocyanidins, which belong to the flavanol type of phenolic compounds (12). The oligomers and polymers of proanthocyanidins in grape seeds possess extensive pharmacological activities and medicinal value (13). At present, the extraction and purification of grape seed extract (GSE) has been achieved and it is commonly used as a dietary supplement (12). Numerous studies have shown that GSE can exert antitumor activity through multiple mechanisms both in vitro and in vivo. GSE not only inhibits the kinase activity of purified VEGFR2 but also blocks the signal pathways regulated by mitogen-activated protein kinases (MAPK) in endothelial cells. It achieves anticancer effects by inhibiting the proliferation and migration of endothelial cells induced by VEGF and the process of vascular regeneration in the aorta, where the water-soluble polyphenol components in grape seeds are the key substances mediating this anti-angiogenic activity (14,15). In terms of promoting apoptosis, grape seed proanthocyanidins can activate caspase-3 to induce tumor cell apoptosis (16–18). In addition, GSE can interfere with the metabolism of purines and pyrimidines by inosine monophosphate dehydrogenase 1/2 inhibition, inducing cell cycle arrest and apoptosis (18,19).

Miracle berry (Synsepalum dulcificum) of the Sapindaceae family is a type of berry that comes from West Africa, named for its ability to convert sourness into sweetness (20). Wagner et al (21) obtained the extract of miracle berry seeds through supercritical fluid extraction technology. This extract is rich in pentacyclic triterpenoids and can notably inhibit mitochondrial respiration, deplete ATP and target the inhibition of cancer-related lipid metabolism, indicating its potential as a cancer metabolic inhibitor. Lupeol, a representative pentacyclic triterpenoid of this class, has itself been shown to exert marked anti-proliferation effects on cancer cells, and this activity has been verified in hepatocellular carcinoma, osteosarcoma, colorectal cancer and other tumor models (22–24).

Blackberry seeds (Rubus spp. L., Rosaceae) belong to the small berries of the Rosaceae family and have a high content of anthocyanins in their fruits. Due to their diverse biological activities, these fruits have become a research hotspot (25). Numerous studies have confirmed that their extracts possess multiple pharmacological effects such as antioxidant (26), anti-inflammatory (27), antibacterial (28) and antitumor (29) properties. Choe et al (30) found that the extract of blackberry seed powder could inhibit the expression of IL-1β mRNA induced by lipopolysaccharide in J774A.1 mouse macrophages, and also that it had a notable inhibitory effect on the proliferation of human lymph node carcinoma of the prostate (LNCaP) cells. Further research on glioma indicated that the extract of blackberry fruits could selectively inhibit the viability and proliferation ability of rat C6 and human U87 glioma cell lines and would not interfere with the normal growth of primary astrocytes. This shows a role in tumor cell selectivity (31).

Raspberry (Rubus idaeus L.) is a type of berry belonging to the Rosaceae family and the Rubus genus. It is rich in natural polyphenolic active components, among which ellagic acid is the most typical polyphenol in its fruit (32,33). In vitro studies have shown that ellagitannins extracted from black raspberry seeds and their metabolites, ellagic acid and urolithins, can exert anticancer activity by inducing cell cycle arrest and promoting apoptosis of human HT-29 colon cancer cells (34). Rodriguez et al (35) found that supplementing a diet with 10% (weight/weight) freeze-dried black raspberries in a mouse model of colitis reduced tumor multiplicity and prolonged the length of the colon, but had no notable effect on improving colitis and protecting the mucosa.

Notably, research on the anticancer activity of berry seeds is highly concentrated on grape seeds, while studies on other berry species such as blackberry and raspberry remain relatively preliminary. Most in vitro studies use crude extracts with poorly defined chemical profiles, making it difficult to accurately attribute the observed bioactivities to specific compounds.

Stone fruit seeds

Stone fruits (drupes) are a type of fleshy fruit characterized by a thin epicarp, a fleshy mesocarp and a hard woody endocarp enclosing a single seed. The present review focuses on açaí and date palm, whose seeds are major by-products of fruit processing (36).

Açaí (Euterpe oleracea Mart.) is the drupe fruit of the açaí palm, an Arecaceae species native to the Amazon region. Its fruits are rich in polyphenols. The flesh and peel have been widely reported for their various biological activities such as antioxidant, anti-inflammatory, heart protection and anticancer properties. This is mainly attributed to its key components cyanidin-3-glucoside and cyanidin-3-rutinoside (37,38). Studies have shown that the seeds of the açaí berry account for 85% of the total weight of the fruit and are rich in polyphenolic compounds such as phenolic acids, catechins and proanthocyanidins, indicating their notable pharmacological potential (37,39). In vitro studies have shown that the extract of açaí berry seeds induces autophagy in the MCF-7 breast cancer cell line by altering the ultrastructure of the cells (40). da Silva et al (41) found that the seed oil of açaí berry can induce apoptosis in CACO-2 and HCT-116 cells and interfere with the cell cycle. The water-alcohol extract of açaí berry seeds exhibited antitumor potential in the Ehrlich mouse model of breast cancer, markedly reducing tumor size and improving inflammatory and oxidative stress indicators (42). Filho et al (43) likewise reported that açaí seed extract exhibited cytotoxicity towards LNCaP prostate cancer cells and reduced solid Ehrlich tumor growth in mice, accompanied by antitumor and immunomodulatory effects.

Date palm (Phoenix dactylifera L.) is an important staple food and economic crop in regions such as the Middle East and North Africa. Its seeds are one of the main by-products of the edible pulp of date palm, and their weight usually accounts for 10–15% of the total weight of date palm (44). Studies have shown that the seeds of date palm are rich in numerous bioactive components such as phenolic acids, flavonoids, carotenoids and dietary fibers (45,46). In terms of antitumor mechanisms, date palm seed extract can inhibit the proliferation of liver, lung, colorectal and other cancer cells in a dose-dependent manner (47,48). It also induces cell apoptosis. Khan et al (49) demonstrated that it exerted a pro-apoptotic effect in MDA-MB-231 cells by activating caspase-3. At the mechanism level, the date seed extract downregulates the expression of peroxisome proliferator-activated receptor-γ, CCAAT/enhancer-binding protein α and adiponectin. It upregulates glucose transporter type 4 and phosphorylated AMPK. It also simultaneously upregulates p21 and p53 while inhibiting Bcl-2. This further confirms that it exerts antitumor effects through the apoptotic pathway (50).

However, numerous studies on stone fruit seeds remain at the phenotypic level of cytotoxicity screening, and in-depth mechanistic verification and in vivo efficacy validation are still insufficient.

Pepo fruit (melon) seeds

All pepo fruit belong to the Cucurbitaceae family, including melons, pumpkins, cucumbers and watermelons. Their fruits are large, fleshy gourd fruits, with flat seeds that are rich in oil content. Their seeds are rich in triterpenoids, cucurbitins, protease inhibitors, phenolic compounds and storage proteins (51).

Melon (Cucumis melo L.) is a crop of notable commercial value within the Cucurbitaceae family (52,53). The pharmacological activities of this plant have been widely confirmed, including anti-inflammatory, antioxidant, liver-protective, diuretic, anticancer, anti-ulcer and immune-regulating effects (51,54). A number of components in melons have been verified, such as cucumol A, cucumol B, phenolic compounds, trypsin inhibitors, melon trypsin inhibitor, cucurbitacin B (CuB) and cucurbitacin E (CuE) (54,55). The extract of melon seeds has shown marked anticancer activity against a number of malignant tumors such as leukemia, multiple myeloma, and breast, ovarian, colon, prostate and cervical cancer (55,56). Yuan et al (57) further demonstrated that CuB can increase intracellular reactive oxygen species (ROS) and Ca2+ levels. This increase induces Toll-like receptor 4/NOD-like receptor family pyrin domain containing 3/gasdermin D-dependent pyroptosis. As a result, CuB inhibits the progression of non-small cell lung cancer. In addition, the anticancer activity of CuB is superior to that of CuE. It can induce cell apoptosis and cell cycle arrest through the STAT3-dependent pathway (58), and can also induce the differentiation and apoptosis of human colorectal cancer RCM-1 cells in a dose-dependent manner (59). This provides a mechanism basis for the development and clinical translation of the antitumor potential of melon seed extract.

Watermelon (Citrullus lanatus) belongs to the Cucurbitaceae family (60). Its seeds are rich in numerous key nutrients such as protein, lipids, carbohydrates and dietary fiber (61). Watermelon seeds also possess multiple pharmacological activities, including antibacterial, antioxidant, anti-inflammatory, anti-diabetic, analgesic, preservative, anesthetic and antitumor properties (62). The core bioactive components of watermelon seeds can mostly be separated and extracted from the seed oil, and they have both high nutritional value and potential for medicinal development (63). Among them, the ethanol extract of watermelon seeds shows the most prominent activity. In vitro experiments have confirmed that it has notable concentration-dependent cytotoxic effects on liver cancer and cervical cancer cell lines (64).

Pumpkin (Cucurbita moschata) seeds are rich in a variety of phytochemicals, with palmitic acid, linoleic acid and other fatty acids as the core components. They also contain phenolic acids, flavonoid active monomers, alkaloids, steroids, terpenoids and other secondary metabolites (65). Studies have shown that these active components confer multiple pharmacological effects, such as deworming, lowering blood sugar, anti-depression, antioxidation, antitumor and cell protection effects (65,66). Among them, the antitumor effect has been verified by multiple in vitro experiments. For example, pumpkin seed extract can notably reduce the survival rate of melanoma cells and exhibit strong cytotoxicity (67). Alafaleq et al (68) found that copper-manganese bimetallic nanoparticles biogenically synthesized using pumpkin seed extract exerted a marked anti-proliferative effect on human colon adenocarcinoma HT-29 cells. Nomikos et al (69) further confirmed that pumpkin seed extracts prepared with different solvents, such as water, ethanol, ethyl acetate, acetone and polar lipids, all inhibited the proliferation of human androgen-independent prostate cancer PC-3 cells. Among these, the aqueous extract (200 and 400 µg/ml) and the polar lipid extract (300 µg/ml) induced autophagy, as monitored by the formation of LC3 autophagic puncta.

It should be noted that cucurbitacins, the core active components of melon seeds, have strong cytotoxicity but also potential systemic toxicity, and their therapeutic window needs to be further evaluated in vivo (55,57).

Aggregate fruit seeds

Aggregate fruits generally have special shapes and large seeds. They mainly include plants of the Moraceae and Annonaceae families. Representative seeds are those of the soursop and jackfruit, which are described below.

Soursop (Annona muricata L.) is a tropical plant from the Annonaceae family and is renowned for its various medicinal properties, including antioxidant, anti-inflammatory, antidiabetic and antitumor activities (70). The plant has been extensively explored in medicinal studies worldwide from its leaves, bark and roots to its fruits and seeds (71). In some tropical sub-Saharan countries such as Uganda and Kenya, a number of parts of the soursop are used to treat malaria, stomach pain, parasitic infections, diabetes and cancer (72). It has been reported that there are 212 bioactive compounds in soursop, among which acetogenin is the main component, as well as alkaloids and phenols (73). The seeds are also rich in oils, and the fatty acid and essential oil compositions of Annona seed oils have been well characterized (74). Prasad et al (75) discovered that the flesh of the soursop induces G0/G1 phase arrest and inhibits breast cancer cells. The seed extract has a stronger inhibitory effect, but its mechanism remains unclear. Kariyil et al (76) further revealed that the chloroform components of the seeds can induce S phase arrest and ROS-dependent mitochondrial apoptosis in triple-negative breast cancer cells. These results indicate that the extracts from different parts of the soursop can exert their effects through differentiated cell cycle checkpoints and apoptotic pathways. Among them, the active components in the seeds have notable research value in refractory breast cancer.

Jackfruit (Artocarpus heterophyllus Lam.) is a common economic crop in tropical regions. Its fruit pulp is widely popular, but its seeds are often overlooked. Relevant studies have shown that jackfruit seeds are rich in numerous active components such as saponins, flavonoids, lignans and alkaloids, and that they possess potential antioxidant, anti-inflammatory and anticancer activities (77–79). Jackfruit seed extract has cytotoxicity and anti-proliferative effects on tumor cells, such as liver, breast and colorectal cancer cell lines (80,81), while showing relatively lower cytotoxicity in selected experimental models. Dhani et al (78) further clarified that catechin, ferulic acid and other phenolic components in the fruit pit have high antioxidant capacity and multiple pharmacological properties. They reduce the risk of triple-negative breast cancer by reducing free radical production. Among them, the sugar binding protein Jacalin, found in the seeds, is one of the representative bioactive anticancer components. It shows strong antitumor activity against colon cancer, hematological malignancies and breast cancer (82).

For aggregate fruit seeds, the research on active components is mostly limited to qualitative identification, and the quantitative composition and in vivo anticancer efficacy data are still very scarce.

Summary of group differences in characteristics

Different groups of fruit seeds exhibit marked component specificity and enrichment patterns. Berries are mainly composed of polyphenols, proanthocyanidins anthocyanins, and their research and industrialization are the most mature. Stone fruits are rich in phenolic acids, flavonoids and anthocyanins. Pepo fruits have characteristic components such as cucurbitin, triterpenoids, phenols and oils. Aggregate fruits contain cyclic peptides, alkaloids, plant lectins and other unique substances. Except for berries, the seeds of stone fruits, cucurbitaceous fruits and aggregate fruit are mostly by-products of fruit and vegetable processing, and the mechanisms of most of their anticancer effects still need to be further clarified.

To provide a systematic overview of the current evidence base, Table I summarizes the evidence level and experimental model for each aforementioned fruit seed extract discussed (83–89). As shown, numerous findings derive from in vitro cell line experiments, with only a limited number of studies employing animal models. No clinical trials have been conducted for any of these fruit seed extracts in the context of cancer prevention or treatment, underscoring an important gap between preclinical observations and clinical translation.

Table I.

Evidence levels and experimental models for anticancer activity of individual fruit seed extracts.

Table I.

Evidence levels and experimental models for anticancer activity of individual fruit seed extracts.

Fruit seedMajor extractEvidence levelModel system(Refs.)
Grape seed (V. vinifera)Grape seed proanthocyanidins/proanthocyanidinsIn vitro and in vivoHL-60/ADR, MCF-7, HeLa; endothelial cells; aortic ring; zebrafish xenograft(14,16,17,19,83,84)
Miracle berry seed (S. dulcificum)Pentacyclic triterpenoids (lupeol)In vitroHepatocellular carcinoma, osteosarcoma, colorectal cancer cells(21–24)
Blackberry seed (Rubus spp.)Seed powder extractIn vitroJ774A.1 macrophages; lymph node carcinoma of the prostate; C6, U87 glioma(29–31)
Raspberry seed (R. idaeus)Ellagic acid and ellagitanninsIn vitro and in vivoHT-29 cells; mouse colitis-associated CRC model(34,35)
Açaí seed (E. oleracea)Polyphenol-rich extract; seed oilIn vitro and in vivoMCF-7, CACO-2, HCT-116; Ehrlich mouse model(40–42,85)
Date palm seed (P. dactylifera)Polyphenol extract (date seed extract)In vitroLiver, lung, colorectal; MDA-MB-231(47–50)
Melon seed (C. melo)Cucurbitacin B, cucurbitacin E, trypsin inhibitor (melon trypsin inhibitor)In vitro and in vivoNSCLC; RCM-1; endothelial cells(55–59,86)
Watermelon seed (C. lanatus)Ethanol extractIn vitroHepG2, HeLa(64)
Pumpkin seed (C. moschata)Multi-solvent extractsIn vitroMelanoma; HCT-116; PC-3(67–69)
Soursop seed (A. muricata)Acetogenins; chloroform fraction; N-p-coumaroyl tyramineIn vitroBreast cancer (triple-negative breast cancer); G0/G1 arrest(73–76,87)
Jackfruit seed (A. heterophyllus)Jacalin lectin; phenolic compoundsIn vitroMCF-7; colon; oral squamous cell carcinoma(78,80,88,89)

Main types of chemical components in fruit seeds

Fruit seeds contain a number of bioactive substances such as polyphenols, terpenoids, fatty acids and protein peptides, as well as newly recognized indole derivatives such as phytomelatonin and plant-derived vitamin D analogs. Phytomelatonin is now considered a ubiquitous plant metabolite with antioxidant, immunomodulatory and oncostatic properties, and has been quantified in grapevine berry tissues (90) and in the seeds of date palm and other fruit species (91,92). Vitamin D-like compounds have also been identified in edible plant tissues, where they may act through the vitamin D receptor and related signaling pathways (91). Through multiple pathways and multiple targets, these components synergistically exert anticancer effects. The present review focuses on the aforementioned fruit seeds and summarizes their core anticancer active components. The distribution and functions of the related components are detailed in Table II (93–97). The relative abundance of the six major classes of bioactive phytochemicals across the four categories of fruit seeds is visualized in the hexagonal radar chart (Fig. 2).

Visual comparison of major fruit seed
categories and their characteristic bioactive compounds.

Figure 2.

Visual comparison of major fruit seed categories and their characteristic bioactive compounds.

Table II.

Representative bioactive compounds, molecular targets, anticancer effects and evidence status of the fruit seeds reviewed.

Table II.

Representative bioactive compounds, molecular targets, anticancer effects and evidence status of the fruit seeds reviewed.

A, Polyphenols

Compound class and representativeSourceMain anticancer effectPrimary molecular targetsCancer types investigated(Refs.)
Proanthocyanidins, catechins, gallic acidGrape seedInducing apoptosis, blocking the cell cycle, inhibiting angiogenesis, and regulating epigeneticsVEGFR2, MAPK, caspase-3/9, Bax/Bcl-2, inosine mono-phosphate dehydrogenase 1/2Breast, colon, bladder, leukemia, cervical(83,84)
Anthocyanin-3-glycoside, anthocyanin-3-acerosideAçaí seedActivate the caspase cascade reaction, inhibit proliferation, and improve oxidative stress and inflammationCaspase cascade, reactive oxygen species/NF-κB, cycooxygenase-2Breast cancer, colorectal cancer, prostate cancer(38,40,43)
Ferulic acid, lignansJackfruit seeds, date palm seedsEliminate free radicals, inhibit the NF-κB pathway, and induce apoptosisCaspase-3, p53, NF-κBLiver cancer, colorectal cancer, breast cancer(49,50,78,93)

B, Terpenoids

Compound class and representativeSourceMain anticancer effectPrimary molecular targetsCancer types investigated(Refs.)

AcetogeninsSoursop seedsInhibiting the mitochondrial electron transport chain, depleting ATP, inducing necrosis and apoptosisMitochondrial complex I, cyclin-dependent kinaseTriple-negative breast cancer, colon cancer(73–76,87)
Lupeol, β-amyrin acetateMiracle berry seeds, jackfruit seedsTargeted inhibition of lipid metabolism, anti-proliferation, and regulation of immunityLipid metabolism pathways, inflammatory mediatorsHepatocellular carcinoma, osteosarcoma, colorectal cancer(21–24)

C, Fatty acids

Compound class and representativeSourceMain anticancer effectPrimary molecular targetsCancer types investigated(Refs.)

Linoleic acid, oleic acid, phytosterolsJackfruit seeds, date palm seedsRegulate inflammatory responses, improve the tumor microenvironment, and synergistically enhance antioxidant capacityPeroxisome proli-ferator-activated receptor-γ, AMPKLiver cancer, colorectal cancer, breast cancer(44,63,93–95)

D, Proteins and peptides

Compound class and representativeSourceMain anticancer effectPrimary molecular targetsCancer types investigated(Refs.)

Trypsin inhibitorMelon seedsInhibiting tumor invasion-related proteases, inhibiting angiogenesis, and reducing invasion and metastasisMMPs, angiogenic factorsBreast cancer, colorectal cancer(55,86)
Storage proteinBlack-berry seeds, jackfruit seedsReduce DNA oxidative damage and regulate immunityOxidative stress pathwaysMultiple tumor cell lines(29,96)

E, Indole alkaloids

Compound class and representativeSourceMain anticancer effectPrimary molecular targetsCancer types investigated(Refs.)

Melatonin, indole derivativesGrape seeds, date palm seedsAntioxidant, anti-inflamp matory, chemopreventive and immunomodulatory effects; epigenetic regulationNF-κB, MAPK, epigenetic regulatorsDigestive system tumors, hormone-related tumors(90–92)

F, Vitamin D analogs

Compound class and representativeSourceMain anticancer effectPrimary molecular targetsCancer types investigated(Refs.)

Plant-derived vitamin D analogsEdible plant tissues (limited evidence in fruit seedsAnti-proliferation, pro-differentiationVitamin D receptor, cell cycle regulatorsBreast cancer, colorectal cancer(91,97)

[i] MAPK, mitogen-activated protein kinases.

Mechanisms of anticancer actions of fruit seed extract

The principal molecular mechanisms underlying the anticancer activities of fruit seed extracts in tumor cell and animal models are illustrated in Fig. 3.

Principal molecular mechanisms of
fruit seed extracts in cancer models. DNMT, DNA methyltransferase;
HDAC, histone deacetylase; miR, microRNA; TIMP, tissue inhibitor of
metalloproteinases; CDK, cyclin-dependent kinase; ROS, reactive
oxygen species; COX-2, cyclooxygenase-2; iNOS, inducible nitric
oxide synthase. Created using BioRender (https://biorender.com/7o9d6a8).

Figure 3.

Principal molecular mechanisms of fruit seed extracts in cancer models. DNMT, DNA methyltransferase; HDAC, histone deacetylase; miR, microRNA; TIMP, tissue inhibitor of metalloproteinases; CDK, cyclin-dependent kinase; ROS, reactive oxygen species; COX-2, cyclooxygenase-2; iNOS, inducible nitric oxide synthase. Created using BioRender (https://biorender.com/7o9d6a8).

Induction of cell apoptosis

The dysregulation of apoptosis is an important mechanism of cancer development and drug resistance. Fruit seed extracts can induce tumor cell apoptosis through the endogenous mitochondrial pathway and exogenous death receptor pathway (83,84). In terms of endogenous pathways, grape seed proanthocyanin extract can upregulate Bax, downregulate Bcl-2, reduce mitochondrial membrane potential, promote cytochrome c release and activate caspase-9/3 cascade in breast cancer and colon cancer (84,98). Aglianico grape seed semi-polar extract promotes apoptosis by inhibiting the mouse double minute 2 (MDM2) pathway (99). Jackfruit and açaí seed extracts similarly activate mitochondrial pathways (43,100). Annonaceous acetogenins in soursop seeds interfere with energy metabolism and induce apoptosis or necroptosis by inhibiting complex I of the mitochondrial electron transport chain (87). In terms of the exogenous pathway, açaí seed oil induces apoptosis of colorectal cancer by upregulating the expression of annexin A2 and promoting the direct binding of its main active fatty acid components to annexin A2 (41).

Inhibition of cell proliferation and arrest of the cell cycle

Fruit seed extracts can inhibit cancer by arresting the cell cycle and inhibiting proliferation signaling pathways. GSE and melon and soursop seed extracts can induce G1/S or G2/M phase arrest in tumor cells, and the mechanism is related to the upregulation of cycle-inhibitory proteins and the reduction of cyclin D1, cyclin E and cyclin-dependent kinase activities (19,58,75,76). The half-maximal inhibitory concentration of the lectin extract from jackfruit seeds on MCF7 human breast cancer cells was 125 µg/ml, and this growth-inhibitory effect was associated with cell cycle arrest (80). In terms of proliferation signaling pathways, GSEs can interfere with purine and pyrimidine biosynthesis and MDM2-related pro-survival signaling (19,99), while CuE from melon seeds acts as a tyrosine kinase inhibitor of the EGFR/MAPK axis and reduces activated STAT3, thereby blocking cell division signals upstream (58).

Inhibition of tumor angiogenesis

Tumor angiogenesis and metastasis are key factors leading to recurrence and death. Grape seed proanthocyanidins have been demonstrated to downregulate the expression of VEGF and its receptor VEGFR2, and inhibit the proliferation and migration of endothelial cells (101). A trypsin inhibitor purified from melon seeds (TICMSs) has been shown to inhibit endothelial cell migration and angiogenesis, with molecular docking suggesting interactions with VEGFR1 and αVβ3 integrin (86). Jackfruit seed extracts can downregulate MMP-2 and MMP-9, further weakening vascular remodeling (88). For stone fruits, direct anti-angiogenic evidence is lacking, but açaí seed extract shows antitumor activity in vivo (42,43) and merits evaluation in angiogenesis models. Overall, the active ingredients derived from these plant seeds can inhibit tumor angiogenesis and metastasis through multi-target synergy, demonstrating potential as antitumor adjuvants.

Antioxidant and anti-inflammatory effects

Oxidative stress and chronic inflammation both promote cancer progression (102). The abundant polyphenols and flavonoids in fruit seed extracts can eliminate reactive oxygen free radicals and alleviate DNA oxidative damage (103,104). They can also inhibit the activation of the NF-κB signaling pathway, reduce the levels of inflammatory factors such as TNF-α, IL-6 and IL-1β, and simultaneously downregulate inflammatory-related enzymes such as cyclooxygenase-2 and inducible nitric oxide synthase, thereby reducing the risk of cancer driven by chronic inflammation (43,103,105).

Inhibition of tumor invasion and migration

Tumor invasion and metastasis are the main causes of death in patients with cancer (106), and fruit seed extract can block this malignant process through multiple links, including the suppression of tumor cell migration and invasion and the inhibition of endothelial cell motility. Grape seed proanthocyanidins have been shown to inhibit tumor metastasis to the lungs and improve survival in mouse breast cancer models, by affecting the inhibition of tumor cell proliferation and the induction of apoptosis (84). Rizbi et al (89) found that jackfruit seed water extract and Jacalin lectin inhibited the migration of oral squamous cell carcinoma. TICMSs purified from melon seed water extract have been shown to inhibit endothelial cell proliferation, migration and tubulogenesis and to reduce the secretion of VEGF, MMP-2 and MMP-9 (86).

Epigenetic regulation

In previous years, studies have shown that polyphenolic natural products can exert antitumor effects through epigenetic mechanisms. Grape seed proanthocyanidins have demonstrated the ability to inhibit DNA methyltransferase and histone deacetylase (HDAC) (98,107), and their combination with resveratrol synergistically inhibits breast cancer cell proliferation and induces apoptosis by upregulating Bax and downregulating Bcl-2 (107). In addition, grape seed extract modulates microRNA (miRNA) expression profiles and the miRNA processing machinery, with downstream alterations in NF-κB, β-catenin and MAPK signaling that underlie its antiproliferative and pro-apoptotic activity (108). These epigenetic mechanisms provide new evidence for fruit seed extracts as cancer chemoprevention and adjuvant treatment preparations.

Current challenges and future perspectives

As a byproduct of fruit processing, fruit seeds are rich in polyphenols, terpenoids and other bioactive components, which show notable potential in the field of cancer prevention and treatment. From the perspective of their action characteristics, the selected fruit seed extracts exhibit multi-component and multi-pathway antitumor properties. They can synergistically inhibit cancer by inducing apoptosis, blocking the cell cycle, inhibiting angiogenesis and metastasis, regulating oxidative stress and by epigenetic means, which is different from traditional single-target chemotherapy drugs. This provides a new idea for overcoming tumor drug resistance. Additionally, they have the characteristics of being widely sourced, with low cost and low toxicity to non-cancer cells, making them more suitable as candidate substances for cancer prevention or adjuvant treatment than conventional cytotoxic chemotherapeutic agents, which are generally associated with higher toxicity.

The four groups of berry, stone fruit, pepo and aggregate fruits exhibit clear boundaries and notable differences in component enrichment rules. Berries are mainly composed of polyphenols, anthocyanins and pentacyclic triterpenoids, which have prominent antioxidant, anti-inflammatory and pro-apoptotic activities. Drupes are rich in flavonoids and phenolic acids, with mild components and a wide antitumor spectrum. The core of pepos consists of triterpenoids and protease inhibitors, which have strong cytotoxicity and anti-angiogenesis activities. Aggregate fruits contain unique components such as annonaceous acetogenins and coumaroyl tyramides, which have strong cytotoxicity and unique targeted metabolic inhibitory effects. The differences among these groups directly determine the differences in activity spectra and targets, providing a scientific basis for the precise development of anticancer preparations.

Safety profile and standardization

The safety profile of fruit seed extracts remains insufficiently characterized. Extract composition can vary substantially according to species, cultivar, geographic origin, maturity, extraction solvent, extraction temperature and storage conditions. Consequently, the biological activity observed for one extract cannot necessarily be attributed to another extract prepared from the same fruit species. Standardization based on marker compounds, total phenolic content or a defined chemical fingerprint is therefore necessary before comparing efficacy or toxicity across studies. Published safety data remain scarce. A randomized, double-blind, placebo-controlled pilot trial of a jackfruit seed-based formulation reported no serious adverse events (79).

Bioavailability and pharmacokinetic considerations

A major limitation of the current literature is the frequent use of relatively high concentrations in cancer cell experiments. For example, the half-maximal inhibitory concentrations reported for seed-derived extracts and oils in the studies cited above ranged from 16 to 125 µg/ml (15,80). The effective concentrations reported in vitro may not be achievable in human plasma or tumor tissue after oral administration due to poor absorption, rapid metabolism, protein binding, efflux transport and elimination (3). Polyphenols, for example, may undergo extensive phase II metabolism, including glucuronidation, sulfation and methylation. Therefore, the concentrations of parent compounds used in cell culture should not be interpreted as clinically achievable systemic concentrations without supporting pharmacokinetic data.

Bioavailability may also be affected by the food matrix and by the chemical form of the active constituent. Encapsulation, lipid-based formulations, fermentation or co-administration with absorption-enhancing substances may increase exposure; however, these approaches may also alter tissue distribution and toxicity. Future studies should report pharmacokinetic parameters, including maximum plasma concentration, time to maximum concentration, area under the curve, half-life, tissue distribution and the identity of major metabolites.

Potential drug interactions

Potential interactions with anticancer drugs should be considered before fruit seed extracts are used as complementary agents. Polyphenols and other phytochemicals may affect cytochrome P450 enzymes, UDP-glucuronosyltransferases, P-glycoprotein and other drug transporters. Such interactions could theoretically modify the exposure of chemotherapeutic agents, targeted drugs or immunotherapies. In addition, antioxidant-rich preparations could interfere with therapies whose efficacy partly depends on oxidative stress, although the direction and clinical importance of this interaction remain compound- and treatment-dependent. These possibilities should be evaluated using enzyme assays, transporter studies, microsomes or hepatocytes, and well-designed animal and clinical pharmacokinetic studies.

Toxicity concerns for specific compound classes

Caution is warranted for seed-derived annonaceous acetogenins. Compounds such as annonacin have been reported to inhibit mitochondrial complex I (70,87), which may contribute to anticancer activity but may also produce mitochondrial and neurotoxic effects. Similarly, the presence of cyanogenic glycosides, allergenic proteins or other antinutritional compounds should be evaluated according to the plant species and processing method. Safety assessment should include acute and repeated-dose toxicity, genotoxicity, reproductive toxicity, hepatotoxicity, nephrotoxicity, neurotoxicity and immunotoxicity.

Limitations of dose extrapolation

The translation of experimental doses to humans requires allometric scaling and, more importantly, exposure-based pharmacology rather than simple conversion of concentrations. Finding a concentration that kills cultured cancer cells does not demonstrate that the same concentration can be safely achieved in a patient. At present, fruit seed extracts should therefore be considered investigational candidates rather than established cancer-preventive or anticancer agents. From a botanical resource perspective, all fruit-seed resources discussed in the present review are derived from commonly cultivated edible fruit species, and no protected or endangered plant species are involved.

Conclusions

In general, fruit seeds are a kind of natural anticancer resource with great development potential. Their high-value utilization not only conforms to the concept of green and sustainable development but also provides a new direction for the research and development of natural anticancer drugs. In the future, efforts should be focused on standardizing the preparation and quality control of extracts, systematically conducting safety evaluations, deeply analyzing the synergistic mechanism of multiple components and actively conducting clinical trials. This will promote the transition of fruit seed extracts from basic research to clinical application, making them an important supplement to the comprehensive cancer prevention and treatment system.

Acknowledgements

Not applicable.

Funding

Funding: No funding was received.

Availability of data and materials

Not applicable.

Authors' contributions

JTi was responsible for review conceptualization. JTa was responsible for writing the original draft of the manuscript. CX developed graphical summaries, interpreted corresponding data and contributed to manuscript revision. PW established the literature screening framework, oversaw data extraction and refined the methodology. XZ and ZW were responsible for reviewing and editing the manuscript. All authors have read and approved the final version of the manuscript. Data authentication is not applicable.

Ethics approval and consent to participate

Not applicable.

Patient consent for publication

Not applicable.

Competing interests

The authors declare that they have no competing interests.

References

1 

Bimonte S, Barbieri A, Palma G, Rea D, Luciano A, D'Aiuto M, Arra C and Izzo F: Dissecting the role of curcumin in tumour growth and angiogenesis in mouse model of human breast cancer. Biomed Res Int. 2015:8781342015. View Article : Google Scholar : PubMed/NCBI

2 

Newman DJ and Cragg GM: Natural products as sources of new drugs over the nearly four decades from 01/1981 to 09/2019. J Nat Prod. 83:770–803. 2020. View Article : Google Scholar : PubMed/NCBI

3 

Qian R, Ge J, Fan N, Sun Z, Zhao C, Sun Y, Li Y, Li Y and Fu H: Natural products in cancer prevention and therapy: Current challenges and future directions. MedComm. 7:e705852026. View Article : Google Scholar : PubMed/NCBI

4 

Ionkova I, Shkondrov A, Zarev Y, Kozuharova E and Krasteva I: Anticancer secondary metabolites: From ethnopharmacology and identification in native complexes to biotechnological studies in species of genus Astragalus L. and Gloriosa L. Curr Issues Mol Biol. 44:3884–3904. 2022. View Article : Google Scholar : PubMed/NCBI

5 

Fan X, Guo S, Li W, Wang Y, Bao J, He J and Jin H: Natural products as metabolic modulators to enhance cancer immunotherapy: Reprogramming the tumor microenvironment. Front Immunol. 16:17406442025. View Article : Google Scholar : PubMed/NCBI

6 

‘Aqilah NMN, Rovina K, Felicia WXL and Vonnie JM: A review on the potential bioactive components in fruits and vegetable wastes as value-added products in the food industry. Molecules. 28:26312023. View Article : Google Scholar : PubMed/NCBI

7 

Jain E, Tripathi AD, Agarwal A, Mauraya KK, Rai DC, Mishra R, Singh RB and Fikri AM: Anticancerous compounds in fruits, their extraction, and relevance to food. Functional Foods and Nutraceuticals in Metabolic and Non-communicable Diseases. Singh RB, Watanabe S and Isaza A: Academic Press; Cambridge, MA: pp. 517–532. 2022, View Article : Google Scholar

8 

Fidelis M, de Moura C, Kabbas Junior T, Pap N, Mattila P, Mäkinen S, Putnik P, Bursać Kovaćević D, Tian Y, Yang B and Granato D: Fruit seeds as sources of bioactive compounds: Sustainable production of high value-added ingredients from by-products within circular economy. Molecules. 24:38542019. View Article : Google Scholar : PubMed/NCBI

9 

Emanuele S, Lauricella M, Calvaruso G, D'Anneo A and Giuliano M: Litchi chinensis as a functional food and a source of antitumor compounds: An overview and a description of biochemical pathways. Nutrients. 9:9922017. View Article : Google Scholar : PubMed/NCBI

10 

Jaszczak-Wilke E, Polkowska Ż, Koprowski M, Owsianik K, Mitchell AE and Bałczewski P: Amygdalin: Toxicity, anticancer activity and analytical procedures for its determination in plant seeds. Molecules. 26:22532021. View Article : Google Scholar : PubMed/NCBI

11 

Sławińska N, Prochoń K and Olas B: A review on berry seeds-A special emphasis on their chemical content and health-promoting properties. Nutrients. 15:14222023. View Article : Google Scholar : PubMed/NCBI

12 

Prieur C, Rigaud J, Cheynier V and Moutounet M: Oligomeric and polymeric procyanidins from grape seeds. Phytochemistry. 36:781–784. 1994. View Article : Google Scholar

13 

Jayaprakasha GK, Singh RP and Sakariah KK: Antioxidant activity of grape seed (Vitis vinifera) extracts on peroxidation models in vitro. Food Chem. 73:285–290. 2001. View Article : Google Scholar

14 

Wen W, Lu J, Zhang K and Chen S: Grape seed extract inhibits angiogenesis via suppression of the vascular endothelial growth factor receptor signaling pathway. Cancer Prev Res (Phila). 1:554–561. 2008. View Article : Google Scholar : PubMed/NCBI

15 

Al-Ashmawy GM, Labah DA, Wahba OM, Abdel Ghafar MT and El-Feky OA: Cancer chemo-preventive role of grape seed oil and cisplatin as a combination adjuvant therapy in the treatment of tongue squamous cell carcinoma: A biological in-vitro study. Arch Oral Biol. 151:1056982023. View Article : Google Scholar : PubMed/NCBI

16 

Lin KN, Zhao W, Huang SY and Li H: Grape seed proanthocyanidin extract induces apoptosis of HL-60/ADR cells via the Bax/Bcl-2 caspase-3/9 signaling pathway. Transl Cancer Res. 10:3939–3947. 2021. View Article : Google Scholar : PubMed/NCBI

17 

Li C, Zhang L, Liu C, He X, Chen M and Chen J: Lipophilic grape seed proanthocyanidin exerts anti-cervical cancer effects in HeLa cells and a HeLa-derived xenograft zebrafish model. Antioxidants (Basel). 11:4222022. View Article : Google Scholar : PubMed/NCBI

18 

Abu-Serie MM, El-Faham AA, Ahmad GM and Habashy NH: Unsaponifiable fraction of black Vitis vinifera seed oil attenuates liver cancer progression by targeting apoptosis and key tumor-associated genes: In vitro, in vivo, and in silico studies. Sci Rep. 16:120182026. View Article : Google Scholar : PubMed/NCBI

19 

Han X, Dong S, Wang Y, Fang X, Gu M, Li X, Wu Y and Zhang B: Grape seed proanthocyanidin extract suppresses bladder cancer by dual blockade of IMPDH1/2-mediated purine and pyrimidine nucleotide biosynthesis. J Ethnopharmacol. 366:1216632026. View Article : Google Scholar : PubMed/NCBI

20 

Du L, Shen Y, Zhang X, Prinyawiwatkul W and Xu Z: Antioxidant-rich phytochemicals in miracle berry (Synsepalum dulcificum) and antioxidant activity of its extracts. Food Chem. 153:279–284. 2014. View Article : Google Scholar : PubMed/NCBI

21 

Wagner S, Gómez de Cedrón M, Navarro del Hierro J, Martín-Hernández D, Siles M, Santoyo S, Jaime L, Martín D, Fornari T and Ramírez de Molina R: Biological activities of miracle berry supercritical extracts as metabolic regulators in chronic diseases. Int J Mol Sci. 24:69572023. View Article : Google Scholar : PubMed/NCBI

22 

He Y, Liu F, Zhang L, Wu Y, Hu B, Zhang Y, Li Y and Liu H: Growth inhibition and apoptosis induced by lupeol, a dietary triterpene, in human hepatocellular carcinoma cells. Biol Pharm Bull. 34:517–522. 2011. View Article : Google Scholar : PubMed/NCBI

23 

Tarapore RS, Siddiqui IA, Adhami VM, Spiegelman VS and Mukhtar H: The dietary terpene lupeol targets colorectal cancer cells with constitutively active Wnt/β-catenin signaling. Mol Nutr Food Res. 57:1950–1958. 2013. View Article : Google Scholar : PubMed/NCBI

24 

Zhong J, He C, Xu F, Xu X, Liu L, Xu M, Guo Z, Wang Y, Liao J and Li Y: Lupeol inhibits osteosarcoma progression by up-regulation of HMGA2 via regulating miR-212-3p. J Orthop Surg Res. 15:3742020. View Article : Google Scholar : PubMed/NCBI

25 

Morin P, Howard LR, Tipton J, Brownmiller C, Mauromoustakos A, Threlfall RT, Clark JR and Worthington M: Phenolics and volatiles in Arkansas fresh-market blackberries (Rubus subgenus Rubus Watson). ACS Food Sci Technol. 2:1728–1737. 2022. View Article : Google Scholar

26 

Kiełtyka-Dadasiewicz A, Stryjecka M, Głowacka A, Tarasevičienė Ž and Jabłońska-Trypuć A: Physicochemical properties of berry seeds recovered from pomace and their potential applications in food and cosmetic industries. Int J Mol Sci. 27:412025. View Article : Google Scholar : PubMed/NCBI

27 

Paczkowska-Walendowska M, Gościniak A, Szymanowska D, Szwajgier D, Baranowska-Wójcik E, Szulc P, Dreczka D, Simon M and Cielecka-Piontek J: Blackberry leaves as new functional food? Screening antioxidant, anti-inflammatory and microbiological activities in correlation with phytochemical analysis. Antioxidants (Basel). 10:19452021. View Article : Google Scholar : PubMed/NCBI

28 

Wu H, Di QR, Zhong L, Zhou JZ, Shan CJ, Liu XL and Ma AM: Enhancement on antioxidant, anti-hyperglycemic and antibacterial activities of blackberry anthocyanins by processes optimization involving extraction and purification. Front Nutr. 9:10076912022. View Article : Google Scholar : PubMed/NCBI

29 

Wang S, Zhao F, Wu W, Lyu L and Li W: Proteins from blackberry seeds: Extraction, Osborne isolate, characteristics, functional properties, and bioactivities. Int J Mol Sci. 24:153712023. View Article : Google Scholar : PubMed/NCBI

30 

Choe U, Li Y, Yu L, Gao B, Wang TTY, Sun J, Chen P and Yu LL: Chemical composition of cold-pressed blackberry seed flour extract and its potential health-beneficial properties. Food Sci Nutr. 8:1215–1225. 2020. View Article : Google Scholar : PubMed/NCBI

31 

da Silveira LM, Pedra NS, Bona NP, Saraiva JT, dos Santos FS, da Rosa TM, de Mello JE, da Silva JA, da Silva GBO, Spanevello RM, et al: Antitumorigenic activity of Rubus sp. fruit extract in C6 rat and U87 human glioma cell lines. Nutrition. 147:1131792026. View Article : Google Scholar : PubMed/NCBI

32 

Tao M, Mao J, Wang G, Jiang Y, Li G, Zhang K, Sun L and Yang G: Ellagitannins from red raspberry (Rubus idaeus L.): A comprehensive review on chemistry characteristics and beneficial effects. Food Funct. 17:1127–1144. 2026. View Article : Google Scholar : PubMed/NCBI

33 

Lopez-Corona AV, Valencia-Espinosa I, González-Sánchez FA, Sánchez-López AL, Garcia-Amezquita LE and Garcia-Varela R: Antioxidant, anti-inflammatory and cytotoxic activity of phenolic compound family extracted from raspberries (Rubus idaeus): A general review. Antioxidants (Basel). 11:11922022. View Article : Google Scholar : PubMed/NCBI

34 

Cho H, Jung H, Lee H, Yi HC, Kwak HK and Hwang KT: Chemopreventive activity of ellagitannins and their derivatives from black raspberry seeds on HT-29 colon cancer cells. Food Funct. 6:1675–1683. 2015. View Article : Google Scholar : PubMed/NCBI

35 

Rodriguez DM, Hintze KJ, Rompato G, Van Wettere AJ, Ward RE, Phatak S, Neal C, Armbrust T, Stewart EC, Thomas AJ and Benninghoff AD: Dietary supplementation with black raspberries altered the gut microbiome composition in a mouse model of colitis-associated colorectal cancer, although with differing effects for a healthy versus a Western basal diet. Nutrients. 14:52702022. View Article : Google Scholar : PubMed/NCBI

36 

Lara MV, Bonghi C, Famiani F, Vizzotto G, Walker RP and Drincovich MF: Stone fruit as biofactories of phytochemicals with potential roles in human nutrition and health. Front Plant Sci. 11:5622522020. View Article : Google Scholar : PubMed/NCBI

37 

Pacheco-Palencia LA, Duncan CE and Talcott ST: Phytochemical composition and thermal stability of two commercial açaí species, Euterpe oleracea and Euterpe precatoria. Food Chem. 115:1199–1205. 2009. View Article : Google Scholar

38 

Vera de Rosso V, Hillebrand S, Cuevas Montilla E, Bobbio FO, Winterhalter P and Mercadante AZ: Determination of anthocyanins from acerola (Malpighia emarginata DC.) and açaí (Euterpe oleracea Mart.) by HPLC-PDA-MS/MS. J Food Compos Anal. 21:291–299. 2008. View Article : Google Scholar

39 

Dias KKB, de Jesus GA, da Costa AAF, Costa FF, Rocha Filho GN, Oliveira RJ, Noronha RCR and Nascimento LAS: Biological activities from açaí (Euterpe spp. Mart.) seeds and their pharmacological aspects: A systematic review and meta-analysis. PharmaNutrition. 29:1004052024. View Article : Google Scholar

40 

da Silva MACN, Soares CS, Borges KRA, Wolff LAS, Barbosa MCL, Nascimento MDSB and de Carvalho JE: Ultrastructural changes induced by açaí (Euterpe oleracea Mart) in MCF-7 breast cancer cell line. Ultrastruct Pathol. 46:511–518. 2022. View Article : Google Scholar : PubMed/NCBI

41 

da Silva MACN, Tessmann JW, Borges KRA, Wolff LAS, Botelho FD, Vieira LA, Morgado-Diaz JA, França TCC, Barbosa MCL, Nascimento MDSB, et al: Açaí (Euterpe oleracea Mart.) seed oil exerts a cytotoxic role over colorectal cancer cells: Insights of annexin A2 regulation and molecular modeling. Metabolites (Basel). 13:7892023. View Article : Google Scholar

42 

Custódio Neto da Silva MA, Araújo Souza Wolff L, Assunção Borges KR, Alvares Marques Vale A, Silva de Azevedo-Santos AP, Pascoal Xavier MA, Lacerda Barbosa MC, Soares Brandão Nascimento MD and Ernesto de Carvalho J: Açaí (Euterpe oleracea Mart.) byproduct reduces tumor size and modulates inflammation in Ehrlich mice model. J Funct Foods. 103:1054742023. View Article : Google Scholar

43 

Filho WEM, Almeida-Souza F, Vale AAM, Victor EC, Rocha MCB, Silva GX, Teles AM, Nascimento FRF, Moragas-Tellis CJ, Chagas MSD, et al: Antitumor effect of açaí (Euterpe oleracea Mart.) seed extract in LNCaP cells and in the solid Ehrlich carcinoma model. Cancers (Basel). 15:25442023. View Article : Google Scholar : PubMed/NCBI

44 

Nehdi I, Omri S, Khalil MI and Al-Resayes SI: Characteristics and chemical composition of date palm (Phoenix canariensis) seeds and seed oil. Ind Crops Prod. 32:360–365. 2010. View Article : Google Scholar : PubMed/NCBI

45 

Alharbi NA, Alsanie SA, Ali AA, Alhosain A, Albrahim T, Aljutaily T, Aljumayi H, Mohamed Ahmed IA, Mohammed BM and Khalil NA: Exploring the functional potential of date (Phoenix dactylifera) seed bioactives in modulating gut microbiota in diabetic rats. Food Sci Nutr. 14:e718412026. View Article : Google Scholar : PubMed/NCBI

46 

Lani MN, Fazel M, Razali MR, Rajak M, Krishnan A, Ismail A, Mohd Lazaldin M, Lambuk L, Mohamud R, Yahaya M, et al: Nutraceuticals of Phoenix dactylifera L.: Physicochemistry, nutritional value and therapeutic potential. Drug Des Devel Ther. 20:5838622026. View Article : Google Scholar : PubMed/NCBI

47 

Swaidan A, Azakir B, Neugart S, Kattour N, Sokhn ES, Osaili TM and El Darra N: Evaluation of the phenolic composition and biological activities of six aqueous date (Phoenix dactylifera L.) seed extracts originating from different countries: A comparative analysis. Foods. 13:1262023. View Article : Google Scholar : PubMed/NCBI

48 

Habib HM, El-Fakharany EM, Souka UD, Elsebaee FM, El-Ziney MG and Ibrahim WH: Polyphenol-rich date palm fruit seed (Phoenix dactylifera L.) extract inhibits labile iron, enzyme, and cancer cell activities, and DNA and protein damage. Nutrients. 14:35362022. View Article : Google Scholar : PubMed/NCBI

49 

Khan MA, Singh R, Siddiqui S, Ahmad I, Ahmad R, Upadhyay S, Barkat MA, Ali AMA, Zia Q, Srivastava A, et al: Anticancer potential of Phoenix dactylifera L. seed extract in human cancer cells and pro-apoptotic effects mediated through caspase-3 dependent pathway in human breast cancer MDA-MB-231 cells: An in vitro and in silico investigation. BMC Complement Med Ther. 22:682022. View Article : Google Scholar : PubMed/NCBI

50 

Hilary S, Kizhakkayil J, Souka U, Al-Meqbaali F, Ibrahim W and Platat C: In-vitro investigation of polyphenol-rich date (Phoenix dactylifera L.) seed extract bioactivity. Front Nutr. 8:6675142021. View Article : Google Scholar : PubMed/NCBI

51 

Peña M, Guzmán A, Mesas C, Porres JM, Martínez R, Bermúdez F, Melguizo C, Cabeza L and Prados J: Evaluation of the leaves and seeds of Cucurbitaceae plants as a new source of bioactive compounds for colorectal cancer prevention and treatment. Nutrients. 16:42332024. View Article : Google Scholar : PubMed/NCBI

52 

Chen S, Zhong K, Li Y, Bai C, Xue Z and Wu Y: Evolutionary analysis of the melon (Cucumis melo L.) GH3 gene family and identification of GH3 genes related to fruit growth and development. Plants (Basel). 12:13822023.PubMed/NCBI

53 

Napolitano M, Terzaroli N, Kashyap S, Russi L, Jones-Evans E and Albertini E: Exploring heterosis in melon (Cucumis melo L.). Plants (Basel). 9:2822020.PubMed/NCBI

54 

Manchali S, Chidambara Murthy KN and Vishnuvardana Patil BS: Nutritional composition and health benefits of various botanical types of melon (Cucumis melo L.). Plants (Basel). 10:17552021.PubMed/NCBI

55 

Raja Soh RSS, Hapidin H and Kasiram MZ: A scoping review on Cucumis melo and its anti-cancer properties. Malays J Med Sci. 31:63–77. 2024. View Article : Google Scholar : PubMed/NCBI

56 

Zhang X, Bai Y, Wang Y, Wang C, Fu J, Gao L, Liu Y, Feng J, Swamy MK, Yogi M, et al: Anticancer properties of different solvent extracts of Cucumis melo L. seeds and whole fruit and their metabolite profiling using HPLC and GC-MS. Biomed Res Int. 2020:52829492020. View Article : Google Scholar : PubMed/NCBI

57 

Yuan R, Zhao W, Wang QQ, He J, Han S, Gao H, Feng Y and Yang S: Cucurbitacin B inhibits non-small cell lung cancer in vivo and in vitro by triggering TLR4/NLRP3/GSDMD-dependent pyroptosis. Pharmacol Res. 170:1057482021. View Article : Google Scholar : PubMed/NCBI

58 

Jing SY, Wu ZD, Zhang TH, Zhang J and Wei ZY: In vitro antitumor effect of cucurbitacin E on human lung cancer cell line and its molecular mechanism. Chin J Nat Med. 18:483–490. 2020.PubMed/NCBI

59 

Kamimura M, Sasaki A, Otani Y, Nakamura Y, Nakamura T, Kuramochi K, Imai T, Kubo N and Okamoto S: Methylthioacetic acid, a derivative of aroma compounds from Cucumis melo var. conomon dose-dependently triggers differentiation and apoptosis of RCM-1 human colorectal cancer cells. J Toxicol Sci. 48:25–35. 2023. View Article : Google Scholar : PubMed/NCBI

60 

Assefa AD, Hur OS, Ro NY, Lee JE, Hwang AJ, Kim BS, Rhee JH, Yi JY, Kim JH, Lee HS, et al: Fruit morphology, citrulline, and arginine levels in diverse watermelon (Citrullus lanatus) germplasm collections. Plants (Basel). 9:10542020.PubMed/NCBI

61 

Neglo D, Tettey CO, Essuman EK, Kortei NK, Boakye AA, Hunkpe G, Amarh F, Kwashie P and Devi WS: Comparative antioxidant and antimicrobial activities of the peels, rind, pulp and seeds of watermelon (Citrullus lanatus) fruit. Sci Afr. 11:e005822021.

62 

Nissar J, Sidiqi US, Dar AH and Akbar U: Nutritional composition and bioactive potential of watermelon seeds: A pathway to sustainable food and health innovation. Sustain Food Technol. 3:375–395. 2025. View Article : Google Scholar : PubMed/NCBI

63 

Shah AA, Gupta A, Aqueel-Ur-Rehman, Kapoor S, Kaur H, Rohilla B, Rashmi K and Bajpai AB: GC-MS analysis of phytoactive compounds, antioxidant and antibacterial activity of Citrullus lanatus seeds. Biomed Pharmacol J. 16:73–86. 2023. View Article : Google Scholar

64 

Geethanjali N, Thiyagarajan P, Swathi B, Raja Iswarya G and Suresh U: Citrullus lanatus seed extracts as a source of natural antibacterial and anticancer agents: In vitro evaluation using HeLa and HepG2 cells. Pharmacol Res Nat Prod. 11:1007842026.

65 

Singh A and Kumar V: Nutritional, phytochemical, and antimicrobial attributes of seeds and kernels of different pumpkin cultivars. Food Front. 3:182–193. 2022. View Article : Google Scholar

66 

Dotto JM and Chacha JS: The potential of pumpkin seeds as a functional food ingredient: A review. Sci Afr. 10:e005752020.

67 

Amarante BA, Saccomori E, Bilibio D, Bender JP, da Silva GB, Manica D, Bagatini MD, Bruno AN and Priamo WL: Targeting metastatic melanoma: Pumpkin seed extracts as potential antineoplastic agents. J Supercrit Fluids. 223:1066432025. View Article : Google Scholar

68 

Alafaleq NO, Zughaibi TA, Jabir NR, Khan AU, Khan MS and Tabrez S: Biogenic synthesis of Cu-Mn bimetallic nanoparticles using pumpkin seeds extract and their characterization and anticancer efficacy. Nanomaterials (Basel). 13:12012023. View Article : Google Scholar : PubMed/NCBI

69 

Nomikos T, Gioti K, Tsoukala M and Tenta R: Pumpkin seed extracts inhibit proliferation and induce autophagy in PC-3 androgen insensitive prostate cancer cells. J Med Food. 24:1076–1082. 2021. View Article : Google Scholar : PubMed/NCBI

70 

Zubaidi SN, Mohd Nani H, Ahmad Kamal MS, Abdul Qayyum T, Maarof S, Afzan A, Mohmad Misnan N, Hamezah HS, Baharum SN and Mediani A: Annona muricata: Comprehensive review on the ethnomedicinal, phytochemistry, and pharmacological aspects focusing on antidiabetic properties. Life (Basel). 13:3532023.PubMed/NCBI

71 

Gavamukulya Y, Wamunyokoli F and El-Shemy HA: Annona muricata: Is the natural therapy to most disease conditions including cancer growing in our backyard? A systematic review of its research history and future prospects. Asian Pac J Trop Med. 10:835–848. 2017. View Article : Google Scholar : PubMed/NCBI

72 

Rao SRS, Ponamgi SPD, Kondala KP and Peela S: Antimicrobial and antiparasitic efficacy of Annona muricata: A review on its role in infectious diseases. Scope. 15:174–180. 2025.

73 

Fallon Adido HE, Silva Chagas CK, Ferreira GG, Carmo Bastos ML and Dolabela MF: In silico studies on cytotoxicity and antitumoral activity of acetogenins from Annona muricata L. Front Chem. 11:13167792023. View Article : Google Scholar : PubMed/NCBI

74 

Wélé A, Ndoye I and Badiane M: Fatty acid and essential oil compositions of the seed oil of five Annona species. Niger J Nat Prod Med. 8:62–65. 2004.

75 

Prasad SK, Veeresh PM, Ramesh PS, Natraj SM, Madhunapantula SV and Devegowda D: Phytochemical fractions from Annona muricata seeds and fruit pulp inhibited the growth of breast cancer cells through cell cycle arrest at G0/G1 phase. J Cancer Res Ther. 16:1235–1249. 2020. View Article : Google Scholar : PubMed/NCBI

76 

Kariyil BJ, Ayyappan UPT, Gopalakrishnan A and George AJ: Chloroform fraction of methanolic extract of seeds of Annona muricata induce S phase arrest and ROS dependent caspase activated mitochondria-mediated apoptosis in triple-negative breast cancer. Anticancer Agents Med Chem. 21:1250–1265. 2021. View Article : Google Scholar : PubMed/NCBI

77 

Taesuk N, Wang A, Srikaew M, Chumroenphat T, Barile D, Siriamornpun S and Bunyatratchata A: Phytochemical profiling of Thai plant-based milk alternatives: Insights into bioactive compounds, antioxidant activities, prebiotics, and amino acid abundance. Food Chem X. 27:1024022025. View Article : Google Scholar : PubMed/NCBI

78 

Dhani S, Hamid Ngobese NZ, Sharma S and Jaiswal AK: A comprehensive review on nutritional composition, health benefits, and industrial applications of jackfruit seeds. J Agric Food Res. 19:1016922025.

79 

Purohit G, Dayalkar P, Bhat R, Iyer J, Nadkarni S and Shahapurkar O: Randomised, double-blind, placebo-controlled pilot clinical trial of jackfruit seed extract formulation (JaSE) for allergic rhinitis treatment. medRxiv. Aug 29–2025.doi: 10.1101/2025.08.24.25334210. PubMed/NCBI

80 

Zuraidah MA, John BA and Kamaruzzaman Y: Cytotoxicity on MCF-7 cell lines exposed to an extract of the Jacalin from jackfruit seed. Sci Herit J. 1:16–18. 2017. View Article : Google Scholar

81 

Trejo Rodríguez IS, Alcántara Quintana LE, Algara Suarez P, Ruiz Cabrera MA and Grajales Lagunes A: Physicochemical properties, antioxidant capacity, prebiotic activity and anticancer potential in human cells of jackfruit (Artocarpus heterophyllus) seed flour. Molecules. 26:48542021. View Article : Google Scholar : PubMed/NCBI

82 

Ghosh P, Muhasina KM, Pandey N and Basavan D: Jackfruit waste: An invented anticancer therapy using jacalin lectin from jackfruit seed. Anticancer Drugs. 34:1085–1093. 2023. View Article : Google Scholar : PubMed/NCBI

83 

Singh T, Sharma SD and Katiyar SK: Grape proanthocyanidins induce apoptosis by loss of mitochondrial membrane potential of human non-small cell lung cancer cells in vitro and in vivo. PLoS One. 6:e274442011. View Article : Google Scholar : PubMed/NCBI

84 

Mantena SK, Baliga MS and Katiyar SK: Grape seed proanthocyanidins induce apoptosis and inhibit metastasis of highly metastatic breast carcinoma cells. Carcinogenesis. 27:1682–1691. 2006. View Article : Google Scholar : PubMed/NCBI

85 

Zafra-Stone S, Yasmin T, Bagchi M, Chatterjee A, Vinson JA and Bagchi D: Berry anthocyanins as novel antioxidants in human health and disease prevention. Mol Nutr Food Res. 51:675–683. 2007. View Article : Google Scholar : PubMed/NCBI

86 

Rasouli H, Parvaneh S, Mahnam A, Rastegari-Pouyani M, Hoseinkhani Z and Mansouri K: Anti-angiogenic potential of trypsin inhibitor purified from Cucumis melo seeds: Homology modeling and molecular docking perspective. Int J Biol Macromol. 96:118–128. 2017. View Article : Google Scholar : PubMed/NCBI

87 

Ilango S, Sahoo DK, Paital B, Kathirvel K, Gabriel JI, Subramaniam K, Jayachandran P, Dash RK, Hati AK, Behera TR, et al: A review on Annona muricata and its anticancer activity. Cancers (Basel). 14:45392022. View Article : Google Scholar : PubMed/NCBI

88 

Thiruselvi M and Durairaj B: In vitro and in vivo antiangiogenic effect of Artocarpus heterophyllus seed extract. Asian J Pharm Clin Res. 11:2682018. View Article : Google Scholar

89 

Rizbi ASF, Abu Bakar MEM, Engku Ngah Sayuddin EN and Rostam MA: Extraction of local Artocarpus heterophyllus (jackfruit) seeds and its effects on the migration of oral squamous cell carcinoma (OSCC). Int J Allied Health Sci. 9 (Suppl 3):S159–S163. 2025.

90 

Vitalini S, Gardana C, Zanzotto A, Simonetti P, Faoro F, Fico G and Iriti M: The presence of melatonin in grapevine (Vitis vinifera L.) berry tissues. J Pineal Res. 51:331–337. 2011. View Article : Google Scholar : PubMed/NCBI

91 

Kim TK, Slominski RM, Pyza E, Kleszczynski K, Tuckey RC, Reiter RJ, Holick MF and Slominski AT: Evolutionary formation of melatonin and vitamin D in early life forms: Insects take centre stage. Biol Rev Camb Philos Soc. 99:1772–1790. 2024. View Article : Google Scholar : PubMed/NCBI

92 

Meenu M, Faizan M, Sharma KP, Giri L, Sobti AK, Bansal V and Garg M: Phytomelatonin: History, biosynthesis, and functions. Melatonin in Plants: Role in Plant Growth, Development, and Stress Response. Sharma A and Ahammed GJ: Springer Nature; Singapore: pp. 1–18. 2024

93 

Maqsood S, Adiamo O, Ahmad M and Mudgil P: Bioactive compounds from date fruit and seed as potential nutraceutical and functional food ingredients. Food Chem. 308:1255222020. View Article : Google Scholar : PubMed/NCBI

94 

Al-Farsi M, Alasalvar C, Al-Abid M, Al-Shoaily K, Al-Amry M and Al-Rawahy F: Compositional and functional characteristics of dates, syrups, and their by-products. Food Chem. 104:943–947. 2007. View Article : Google Scholar

95 

Alkhoori MA, Kong ASY, Aljaafari MN, Abushelaibi A, Erin Lim SH, Cheng WH, Chong CM and Lai KS: Biochemical composition and biological activities of date palm (Phoenix dactylifera L.) seeds: A review. Biomolecules (Basel). 12:16262022. View Article : Google Scholar

96 

Wu J, Zhou X, Zhou L, Liu W, Zhong J, Zhang Y and Liu C: Physicochemical, structural, and functional properties of protein fractions and protein isolate from jackfruit seeds. J Food Sci. 87:1540–1551. 2022. View Article : Google Scholar : PubMed/NCBI

97 

Boulila A and Bejaoui A: Lycium intricatum Boiss.: An unexploited and rich source of unsaturated fatty acids, 4-desmethylsterols and other valuable phytochemicals. Lipids Health Dis. 14:592015. View Article : Google Scholar : PubMed/NCBI

98 

Habib HM, El-Fakharany EM, Kheadr E and Ibrahim WH: Grape seed proanthocyanidin extract inhibits DNA and protein damage and labile iron, enzyme, and cancer cell activities. Sci Rep. 12:123932022. View Article : Google Scholar : PubMed/NCBI

99 

Cuciniello R, Di Meo F, Sulli M, Demurtas OC, Tanori M, Mancuso M, Villano C, Aversano R, Carputo D, Baldi A, et al: Aglianico grape seed semi-polar extract exerts anticancer effects by modulating MDM2 expression and metabolic pathways. Cells (Basel). 12:2102023.

100 

Lee CW, Hsu LF, Lee MH, Lee IT, Liu JF, Chiang YC and Tsai MH: Extracts of Artocarpus communis induce mitochondria-associated apoptosis via pro-oxidative activity in human glioblastoma cells. Front Pharmacol. 9:4112018. View Article : Google Scholar : PubMed/NCBI

101 

Unusan N: Proanthocyanidins in grape seeds: An updated review of their health benefits and potential uses in the food industry. J Funct Foods. 67:1038612020. View Article : Google Scholar

102 

Acevedo-León D, Gómez-Abrill SÁ, Sanz-García P, Estañ-Capell N, Bañuls C and Sáez G: The role of oxidative stress, tumor and inflammatory markers in colorectal cancer patients: A one-year follow-up study. Redox Biol. 62:1026622023. View Article : Google Scholar : PubMed/NCBI

103 

Mancini M, Cerny MEV, Cardoso NS, Verissimo G and Maluf SW: Grape seed components as protectors of inflammation, DNA damage, and cancer. Curr Nutr Rep. 12:141–150. 2023. View Article : Google Scholar : PubMed/NCBI

104 

Simonovic M, Kojic V, Jakimov D, Glumac M and Pejin B: Raspberry seeds extract selectively inhibits the growth of human lung cancer cells in vitro. Nat Prod Res. 35:2253–2256. 2021. View Article : Google Scholar : PubMed/NCBI

105 

Nelson VK, Nuli MV, Mastanaiah J, Saleem TSM, Birudala G, Jamous YF, Alshargi O, Kotha KK, Sudhan HH, Mani RR, et al: Reactive oxygen species mediated apoptotic death of colon cancer cells: Therapeutic potential of plant derived alkaloids. Front Endocrinol (Lausanne). 14:12011982023. View Article : Google Scholar : PubMed/NCBI

106 

Alshahrani A, Alsubait A, Asiri Z, Alghamdi S, Bin Saqyah S, Alqahtani T, Fitaihi R, Altuwaijri N and Jamous YF: Deciphering molecular pathways driving cancer invasion and metastasis: Advances and therapeutic prospects. Front Oncol. 15:16848962025. View Article : Google Scholar : PubMed/NCBI

107 

Gao Y and Tollefsbol TO: Combinational proanthocyanidins and resveratrol synergistically inhibit human breast cancer cells and impact epigenetic-mediating machinery. Int J Mol Sci. 19:22042018. View Article : Google Scholar : PubMed/NCBI

108 

Derry MM, Raina K, Balaiya V, Jain AK, Shrotriya S, Huber KM, Serkova NJ, Agarwal R and Agarwal C: Grape seed extract efficacy against azoxymethane-induced colon tumorigenesis in A/J mice: Interlinking miRNA with cytokine signaling and inflammation. Cancer Prev Res (Phila). 6:625–633. 2013. View Article : Google Scholar : PubMed/NCBI

Related Articles

  • Abstract
  • View
  • Download
  • Twitter
Copy and paste a formatted citation
Spandidos Publications style
Tang J, Xu C, Tian J, Wang P, Zhang X and Wang Z: Fruit seed extracts: A class of natural anticancer candidate resources (Review). Oncol Lett 33: 8, 2027.
APA
Tang, J., Xu, C., Tian, J., Wang, P., Zhang, X., & Wang, Z. (2027). Fruit seed extracts: A class of natural anticancer candidate resources (Review). Oncology Letters, 33, 8. https://doi.org/10.3892/ol.2026.15943
MLA
Tang, J., Xu, C., Tian, J., Wang, P., Zhang, X., Wang, Z."Fruit seed extracts: A class of natural anticancer candidate resources (Review)". Oncology Letters 33.1 (2027): 8.
Chicago
Tang, J., Xu, C., Tian, J., Wang, P., Zhang, X., Wang, Z."Fruit seed extracts: A class of natural anticancer candidate resources (Review)". Oncology Letters 33, no. 1 (2027): 8. https://doi.org/10.3892/ol.2026.15943
Copy and paste a formatted citation
x
Spandidos Publications style
Tang J, Xu C, Tian J, Wang P, Zhang X and Wang Z: Fruit seed extracts: A class of natural anticancer candidate resources (Review). Oncol Lett 33: 8, 2027.
APA
Tang, J., Xu, C., Tian, J., Wang, P., Zhang, X., & Wang, Z. (2027). Fruit seed extracts: A class of natural anticancer candidate resources (Review). Oncology Letters, 33, 8. https://doi.org/10.3892/ol.2026.15943
MLA
Tang, J., Xu, C., Tian, J., Wang, P., Zhang, X., Wang, Z."Fruit seed extracts: A class of natural anticancer candidate resources (Review)". Oncology Letters 33.1 (2027): 8.
Chicago
Tang, J., Xu, C., Tian, J., Wang, P., Zhang, X., Wang, Z."Fruit seed extracts: A class of natural anticancer candidate resources (Review)". Oncology Letters 33, no. 1 (2027): 8. https://doi.org/10.3892/ol.2026.15943
Follow us
  • Twitter
  • LinkedIn
  • Facebook
About
  • Spandidos Publications
  • Careers
  • Cookie Policy
  • Privacy Policy
How can we help?
  • Help
  • Live Chat
  • Contact
  • Email to our Support Team